Neural Therapeutics Inc. (CSE:NURL)

Market Cap	2.66M
Revenue (ttm)	n/a
Net Income (ttm)	-1.41M
Shares Out	88.70M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,264
Average Volume	55,904
Open	0.0250
Previous Close	0.0300
Day's Range	0.0250 - 0.0300
52-Week Range	0.0200 - 0.0500
Beta	n/a
RSI	47.24
Earnings Date	Jun 20, 2025

About Neural Therapeutics

Neural Therapeutics Inc., a drug discovery company, focuses on plant-based active substances. It focuses on San Pedro, a cactus containing mescaline and delivers over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments. Neural Therapeutics Inc. was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in November 2021. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2020
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: NURL